Dr. Elise Chong is an Assistant Professor of Medicine in the Division of Hematology/Oncology at the Hospital of the University of Pennsylvania. She is a clinical investigator whose research program develops immunotherapeutic and non-chemotherapy-based approaches to improve the survival and quality of life of patients with B-cell non-Hodgkin lymphomas and chronic lymphocytic leukemia (CLL). She has a current focus on overcoming resistance to currently available, standard of care therapies; in particular, CAR T cell (CAR-T) resistance is one such focus. She has clinical expertise in the care of clinically complex lymphoma and CLL patients and is the Cellular Therapy Lymphoma Disease Lead at Penn.
Elise Chong MD
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
United States
Project Title
Program
Academic Clinical Trials Program (ACT)